CBIO
CBIO
NASDAQ · Biotechnology

Crescent Biopharma Inc

Small-Cap Stocks Biotech Stocks Healthcare Stocks
$16.61
+0.36 (+2.22%)
As of Sep 22, 3:35 PM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 13 87%
Hold 2 13%
Sell 0 0%
Price Target
Analyst Price Target +66.5% upside
Low Target $15.31
Average Target $27.66
High Target $30.74
Current Price $16.61
Current
$16.61
Target
$27.66
$15.31 $27.66 avg $30.74
Scenario Analysis
Bear Case
$15.31
-7.8%
Low target
Base Case
$27.66
+66.5%
Avg target
Bull Case
$30.74
+85.1%
High target
Risk/Reward
10.9x
Highly favorable
Price in Context
52-Week High
$27.41
-39.4% from high
52-Week Low
$8.72
+90.5% from low
Target vs 52W High
$27.66
+0.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
 Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
 Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
 Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
 Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
 Strong Buy 28 93% $114.11 -40.8%